Cytoplasmic SIRT1 enhances the stemness of polyploid giant cancer cells by promoting β-catenin protein stability and nuclear accumulation in ovarian carcinoma upon neoadjuvant chemotherapy
- 2 December 2025
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 639, 218193
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072869)
- National Natural Science Foundation of China (CBSKL2022ZZ27)
- National Natural Science Foundation of China (82273004)
- National Natural Science Foundation of China (CBSKL2022ZZ24)
This publication has 56 references indexed in Scilit:
- Activated PLK1 promotes the migration and invasion of polyploid giant cancer cells with daughter cells via β-catenin/STAT3 signaling pathwayHuman Cell, 2025
- miR-1246 enhances chemo-resistance of polyploid giant cancer cells in H1299 cells by targeting GSK3β/β-cateninDiscover Oncology, 2025
- Cytoplasmic SIRT1 promotes paclitaxel resistance in ovarian carcinoma through increased formation and survival of polyploid giant cancer cellsThe Journal of Pathology, 2023
- Patient-derived organoids in ovarian cancer: Current research and its clinical relevanceBiochemical Pharmacology, 2023
- Molecular characteristics and clinical behaviour of epithelial ovarian cancersCancer Letters, 2023
- BOP1 confers chemoresistance of triple‐negative breast cancer by promoting CBP‐mediated β‐catenin acetylationThe Journal of Pathology, 2021
- Deacetylation of β-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cellsCancer Letters, 2019
- Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial–mesenchymal transition in ovarian carcinomaMolecular and Cellular Biochemistry, 2019
- Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxelInternational Journal of Cancer, 2013
- SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β‐cateninEMBO Molecular Medicine, 2013